To demonstrate equivalency of the Cardica ™ C - Port xA anastomosis compared to hand sutured anastomoses in patients undergoing CABG with respect to 12 months patency at distal anastomosis site.
ID
Bron
Verkorte titel
Aandoening
angina pectoris, coronary disease, CABG, Sutureless anastomoses, vascular connector
Ondersteuning
Drs. J. ter Woorst
Drs. N.J. Verberkmoes
LST Europe
Weiseind 10
5673 BS Nuenen
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
a. Acute: The presence of acute patency of the distal anastomoses as determined by flow measurements intraoperatively.<br>
b. Chronic: The presence of patency of the distal anastomoses as determined by multislice CT - Scan at 12 months. <br>
c. Incidence of device related Adverse Events
Achtergrond van het onderzoek
Coronary Artery Disease (CAD) is the leading cause of death in our society. Either Percutaneous Transluminal Coronary Angioplasty (PTCA), with or without stenting, or Coronary Artery ByPass Grafting (CABG) procedures are typically employed to achieve revascularization of the heart. The Cardica ™ C - Port xA is intended for use in CABG procedures for creating a rapid sutureless end to side directional distal anastomosis between a grafted vessel (vein or artery) and the coronary artery. The Cardica ™ C - Port xA has three possible advantages compared to the standard suturing technique: The Cardica ™ C - Port xA may provide a method for standardizing the anastomosis procedure. Usage of the Cardica ™ C - Port xA may shorten the actual “suturing” period of 10-25 minutes and the period of myocardial ischemia associated with local occlusion of a coronary vessel in OPCAB procedures. For OPCAB cases, shortening the time needed for graft connection will reduce the period of hemodynamic instability frequently associated with heart displacement needed for back wall vessels exposure. Finally, the anastomosis created with a C-Port xA is compliant as opposed to an anastomosis created using the standard running suturing technique, where the anastomosis is non-compliant and is restricted in its ability to expand with increasing blood flow requirements.
Doel van het onderzoek
To demonstrate equivalency of the Cardica ™ C - Port xA anastomosis compared to hand sutured anastomoses in patients undergoing CABG with respect to 12 months patency at distal anastomosis site.
Onderzoeksopzet
1. Perioperative / In Hospital
2. 6 month follow-up (clinical)
3. 12 month follow-up (clinical and CT-scan)
Onderzoeksproduct en/of interventie
Coronary Bypass Surgery
Publiek
Dep. Cardiothoracic Surgery, research and development<br>
Berreklouw
Michelangelolaan 2
Eindhoven 5623 EJ
The Netherlands
+31 (0)40 2398680
Wetenschappelijk
Dep. Cardiothoracic Surgery, research and development<br>
Berreklouw
Michelangelolaan 2
Eindhoven 5623 EJ
The Netherlands
+31 (0)40 2398680
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Abe to give informed consent able to understand the intent and clinical meaning of the study as well as its implication.
2. Patients 18 years old or older.
3. Willing and able to have follow-up visits and examinations.
4. Standard Euroscore < 2.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Procedure is done as an emergency operation.
2. Unable to meet study requirements, i.e. mobility challenge.
3. Participation in any other clinical trial.
4. Pregnancy.
5. Not a standard CABG operation or is concomitant with heart valve surgery.
6. History of any cardiac surgery other than PTCA and stent placement.
7. History of IABP within the last 30 days.
8. Congestive heart failure or been classified NYHA Class IV in the last 30 days.
9. History of bleeding disorder or history of thromboembolic disease requiring anticoagulation therapy.
10. Hemodynamically unstable.
11. History of acute or chronic dialysis.
12. Creatinine level of > 200 mmol/ml or 2,3 mg/dL in the last 30 days.
13. Documented or suspected acute systemic infection.
14. Need for immunosuppressive therapy.
15. Cerebrovascular accident within the last 2 weeks.
16. Allergy or other contraindication for aspirin or other anticoagulant/antiplatelet therapy
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL1349 |
NTR-old | NTR1409 |
Ander register | : NJV_130679 |
ISRCTN | ISRCTN wordt niet meer aangevraagd |